Our study identifies an NEAT1/miR-214-3p pathway in regulating angiogenesis and cancer metastasis, and suggests that the approaches targeting the molecules in this pathway can be utilized to treat ovarian cancer. The gene discussed is NEAT1; the disease is ovarian carcinoma.